市場調查報告書

失眠症治療藥的全球市場分析

Global Market Study on Insomnia Treatment: High Demand for OTC Sleep Aids & OTC Sleep Supplements to Persist

出版商 Persistence Market Research 商品編碼 658713
出版日期 內容資訊 英文 163 Pages
商品交期: 2-3個工作天內
價格
Back to Top
失眠症治療藥的全球市場分析 Global Market Study on Insomnia Treatment: High Demand for OTC Sleep Aids & OTC Sleep Supplements to Persist
出版日期: 2018年06月07日內容資訊: 英文 163 Pages
簡介

本報告提供全球失眠症治療藥的市場相關分析,提供產品概要和市場結構,主要的推動及阻礙市場要素,市場規模·佔有率的變化與預測 (過去5年·今後9年份),藥物類別·各流通管道及各地區·主要國家詳細趨勢,目前市場結構·競爭狀態,主要企業簡介等調查。

第1章 摘要整理

第2章 市場概要

第3章 市場動態

  • 宏觀經濟要素
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會分析
  • 市場趨勢

第4章 宏觀經濟的前提條件

第5章 全球經濟的未來展望

  • GDP趨勢預測:各地區·各國 (總計16年份)
  • 醫療市場趨勢預測
  • 醫療市場相關指標

第6章 市場主要趨勢

  • 失眠症的流行病學的狀態:各地區

第7章 北美的失眠症治療藥市場:分析與預測

  • 簡介
  • 域內市場趨勢
  • 市場規模的實際成果值:各國 (以金額為準,過去5年份)
  • 市場規模的預測值:各國 (以金額為準,今後9年份)
    • 美國,加拿大
  • 市場規模:藥物類別 (以金額為準,總計14年份)
  • 市場規模:各流通管道 (以金額為準,總計14年份)
  • 市場向心力分析:各國,藥物類別,各流通管道

第8章 南美的失眠症治療藥市場:分析與預測

  • 市場規模的實際成果值:各國 (以金額為準,過去5年份)
  • 市場規模的預測值:各國 (以金額為準,今後9年份)
    • 阿根廷,巴西,墨西哥等

第9章 歐洲的失眠症治療藥市場:分析與預測

  • 市場規模的實際成果值:各國 (以金額為準,過去5年份)
  • 市場規模的預測值:各國 (以金額為準,今後9年份)
    • 德國,英國,法國,義大利,西班牙,俄羅斯,波蘭等

第10章 亞太地區的失眠症治療藥市場:分析與預測

  • 市場規模的實際成果值:各國 (以金額為準,過去5年份)
  • 市場規模的預測值:各國 (以金額為準,今後9年份)
    • 中國,日本,印度,澳洲·紐西蘭,東南亞國協等

第11章 中東·非洲的失眠症治療藥市場:分析與預測

  • 市場規模的實際成果值:各國 (以金額為準,過去5年份)
  • 市場規模的預測值:各國 (以金額為準,今後9年份)
    • 波灣合作理事會 (GCC) 各國,南非等

第12章 預測要素:相關性及影響度

第13章 企業分析

  • 市場參與企業一覽
  • 企業的互相比較
  • 盈利·祖先報酬率分析:各企業
  • 企業的詳細分析
    • Merck & Co. Inc.
      • 概要
      • 產品·技術組合
      • 生產·銷售·流通據點的分佈情形
      • 企業策略 (行銷/產品/銷售管道策略)
    • Natrol, LLC
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Pfizer Inc.
    • Boehringer Ingelheim International GmbH
    • Mallinckrodt
    • PERNIX Therapeutics
    • 武田藥品工業
    • Sunovion Pharmaceuticals, Inc.

第14章 全球失眠症治療藥市場:分析與預測,各地區

  • 簡介/分析概要
  • 市場規模的實際成果值:各地區 (以金額為準,過去5年份)
  • 市場規模的預測值:各地區 (以金額為準,今後9年份)
    • 北美
    • 南美
    • 歐洲
    • 亞太地區 (中國以外)
    • 中國
    • 中東·非洲
  • 市場向心力分析:各地區

第15章 全球失眠症治療藥市場:分析與預測,藥物類別

  • 簡介/分析概要
  • 市場規模的實際成果值:藥物類別 (以金額為準,過去5年份)
  • 市場規模的預測值:藥物類別 (以金額為準,今後9年份)
    • 成藥 (OTC)
      • 睡眠補助劑
      • 睡眠用補充品
    • 處方藥
  • 市場向心力分析:藥物類別

第16章 全球失眠症治療藥市場:分析與預測,各流通管道

  • 簡介/分析概要
  • 市場規模的實際成果值:各流通管道 (以金額為準,過去5年份)
  • 市場規模的預測值:各流通管道 (以金額為準,今後9年份)
    • 醫院藥局
    • 一般藥局
    • 電子商務 (電子商務)
    • 藥妝店
    • 其他
  • 市場向心力分析:各流通管道

第17章 全球失眠症治療藥市場:分析與預測 (總計14年份)

  • 市場佔有率分析 (以金額為準)
  • 年度成長率
  • 市場機會的絕對規模

第18章 分析方法

目錄

This report offers a comprehensive forecast of the global insomnia treatment market between 2018 and 2026. The analysis demonstrates market opportunities and trends in the Global Insomnia Treatment Market, which would further influence the segment. The global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices and pharmaceuticals segments.

The Insomnia Treatment Market segmented as follows:

Insomnia Treatment Market , by Drug Type

Insomnia Treatment Market , by End User

Insomnia Treatment Market , by Region

This report encompasses the global insomnia treatment market performance in terms of revenue contribution from various segments and also gives an overview of the insomnia sleep disorder, sleep aids and other definitions. Macro-economic factors influencing growth of the insomnia treatment market along with detailing opportunity analysis of market are also outlined.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments, growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global insomnia treatment market.

The global insomnia treatment market is segmented based on drug type, distribution channel and region. On the basis of drug type market has been segmented as OTC drugs and prescription drugs. On the basis of distribution channel market has been segmented as hospital pharmacies, retail pharmacies, e-commerce and drug stores & hypermarkets. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractiveness index. The report also gives a comprehensive overview of the regional market dynamics along with key growth driver, restraints, and trends pertaining to each region, which can be useful to understand the investment and collaboration opportunities in major countries. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC), and MEA.

Competitive Landscape

This section is included in the report to provide insights on the key players in the global insomnia treatment market and is primarily designed to furnish a detailed comparative assessment of service offerings and strategies of key providers specific to market segments. Detailed profiles of players in insomnia treatment market are also provided in the report which highlights company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

Research Methodology

To arrive at the market size, Persistence Market Research considered parent market statistics i.e. stem cell market in each region and share of insomnia treatment market. A bottom-up approach was used to validate the total market size obtained. The report provides total revenue of insomnia treatment market over the forecast period 2018-2026. While forecasting the market size, several factors such as approvals for insomnia treatment drugs, R&D investment by major players, and consumption of drugs by different end users have been considered. However, to quantifying the market across the aforementioned segments and regions, market expectations and opportunities have been considered. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global insomnia treatment market.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Inclusion and Exclusion

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
  • 3.3. Restraints
  • 3.4. Opportunity Analysis
  • 3.5. Trends

4. Macroeconomic Assumptions

5. Global Economic Outlook

  • 5.1. Gross Domestic Product by Region & Country, 2006 - 2021
  • 5.2. Healthcare Sector Outlook
  • 5.3. Healthcare Indicators

6. Key Inclusions

  • 6.1. Epidemiology of Insomnia, By Region

7. North America Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 7.1. Introduction
  • 7.2. Regional Market Trends
  • 7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 7.5.1. OTC Drugs
      • 7.5.1.1. OTC Sleep Aids
      • 7.5.1.2. OTC Sleep Supplements
    • 7.5.2. Prescription Drugs
  • 7.6. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 7.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 7.7.1. Hospital Pharmacies
    • 7.7.2. Retail Pharmacies
    • 7.7.3. e commerce
    • 7.7.4. Drug Stores
    • 7.7.5. Others
  • 7.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 7.9. Market Attractiveness Analysis
    • 7.9.1. By Country
    • 7.9.2. By Drug Type
    • 7.9.3. By Distribution Channel

8. Latin America Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 8.1. Introduction
  • 8.2. Regional Market Trends
  • 8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 8.3.1. Argentina
    • 8.3.2. Brazil
    • 8.3.3. Mexico
    • 8.3.4. Rest of Latin America
  • 8.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 8.5.1. OTC Drugs
      • 8.5.1.1. OTC Sleep Aids
      • 8.5.1.2. OTC Sleep Supplements
    • 8.5.2. Prescription Drugs
  • 8.6. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 8.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 8.7.1. Hospital Pharmacies
    • 8.7.2. Retail Pharmacies
    • 8.7.3. e commerce
    • 8.7.4. Drug Stores
    • 8.7.5. Others
  • 8.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 8.9. Market Attractiveness Analysis
    • 8.9.1. By Country
    • 8.9.2. By Drug Type
    • 8.9.3. By Distribution Channel

9. Europe Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 9.1. Introduction
  • 9.2. Regional Market Trends
  • 9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Russia
    • 9.3.7. Poland
    • 9.3.8. Rest of Europe
  • 9.4. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 9.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 9.5.1. OTC Drugs
      • 9.5.1.1. OTC Sleep Aids
      • 9.5.1.2. OTC Sleep Supplements
    • 9.5.2. Prescription Drugs
  • 9.6. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 9.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 9.7.1. Hospital Pharmacies
    • 9.7.2. Retail Pharmacies
    • 9.7.3. e commerce
    • 9.7.4. Drug Stores
    • 9.7.5. Others
  • 9.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 9.9. Market Attractiveness Analysis
    • 9.9.1. By Country
    • 9.9.2. By Drug Type
    • 9.9.3. By Distribution Channel

10. Asia Pacific Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 10.1.Introduction
  • 10.2.Regional Market Trends
  • 10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia and New Zealand
    • 10.3.5. ASEAN
    • 10.3.6. Rest of Asia Pacific
  • 10.4.Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 10.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 10.5.1. OTC Drugs
      • 10.5.1.1. OTC Sleep Aids
      • 10.5.1.2. OTC Sleep Supplements
    • 10.5.2. Prescription Drugs
  • 10.6.Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 10.7.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 10.7.1. Hospital Pharmacies
    • 10.7.2. Retail Pharmacies
    • 10.7.3. e commerce
    • 10.7.4. Drug Stores
    • 10.7.5. Others
  • 10.8.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 10.9.Market Attractiveness Analysis
    • 10.9.1. By Country
    • 10.9.2. By Drug Type
    • 10.9.3. By Distribution Channel

11. Middle East & Africa Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 11.1.Introduction
  • 11.2.Key Regulations
  • 11.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 11.3.1. GCC Countries
    • 11.3.2. South Africa
    • 11.3.3. Rest of MEA
  • 11.4.Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 11.5.Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 11.5.1. OTC Drugs
      • 11.5.1.1. OTC Sleep Aids
      • 11.5.1.2. OTC Sleep Supplements
    • 11.5.2. Prescription Drugs
  • 11.6.Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 11.7.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 11.7.1. Hospital Pharmacies
    • 11.7.2. Retail Pharmacies
    • 11.7.3. e commerce
    • 11.7.4. Drug Stores
    • 11.7.5. Others
  • 11.8.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 11.9.Market Attractiveness Analysis
    • 11.9.1. By Country
    • 11.9.2. By Drug Type
    • 11.9.3. By Distribution Channel

12. Forecast Factors: Relevance and Impact

13. Competition Analysis

  • 13.1.Competition Dashboard
  • 13.2.Competition Benchmarking
  • 13.3.Profitability and Gross Margin Analysis By Competition
  • 13.4.Company Deep Dive
    • 13.4.1. Merck & Co. Inc.
      • 13.4.1.1. Overview
      • 13.4.1.2. Product and Technology Portfolio
      • 13.4.1.3. Production Footprint
      • 13.4.1.4. Sales Footprint
      • 13.4.1.5. Channel Footprint
      • 13.4.1.6. Strategy
        • 13.4.1.6.1.1. Marketing Strategy
        • 13.4.1.6.1.2. Product Strategy
        • 13.4.1.6.1.3. Channel Strategy
    • 13.4.2. Natrol, LLC
      • 13.4.2.1. Overview
      • 13.4.2.2. Product and Technology Portfolio
      • 13.4.2.3. Production Footprint
      • 13.4.2.4. Sales Footprint
      • 13.4.2.5. Channel Footprint
      • 13.4.2.6. Strategy
        • 13.4.2.6.1.1. Marketing Strategy
        • 13.4.2.6.1.2. Product Strategy
        • 13.4.2.6.1.3. Channel Strategy
    • 13.4.3. GlaxoSmithKline Plc.
      • 13.4.3.1. Overview
      • 13.4.3.2. Product and Technology Portfolio
      • 13.4.3.3. Production Footprint
      • 13.4.3.4. Sales Footprint
      • 13.4.3.5. Channel Footprint
      • 13.4.3.6. Strategy
        • 13.4.3.6.1.1. Marketing Strategy
        • 13.4.3.6.1.2. Product Strategy
        • 13.4.3.6.1.3. Channel Strategy
    • 13.4.4. Sanofi SA
      • 13.4.4.1. Overview
      • 13.4.4.2. Product and Technology Portfolio
      • 13.4.4.3. Production Footprint
      • 13.4.4.4. Sales Footprint
      • 13.4.4.5. Channel Footprint
      • 13.4.4.6. Strategy
        • 13.4.4.6.1.1. Marketing Strategy
        • 13.4.4.6.1.2. Product Strategy
        • 13.4.4.6.1.3. Channel Strategy
    • 13.4.5. Pfizer Inc.
      • 13.4.5.1. Overview
      • 13.4.5.2. Product and Technology Portfolio
      • 13.4.5.3. Production Footprint
      • 13.4.5.4. Sales Footprint
      • 13.4.5.5. Channel Footprint
      • 13.4.5.6. Strategy
        • 13.4.5.6.1.1. Marketing Strategy
        • 13.4.5.6.1.2. Product Strategy
        • 13.4.5.6.1.3. Channel Strategy
    • 13.4.6. Boehringer Ingelheim International GmbH
      • 13.4.6.1. Overview
      • 13.4.6.2. Product and Technology Portfolio
      • 13.4.6.3. Production Footprint
      • 13.4.6.4. Sales Footprint
      • 13.4.6.5. Channel Footprint
      • 13.4.6.6. Strategy
        • 13.4.6.6.1.1. Marketing Strategy
        • 13.4.6.6.1.2. Product Strategy
        • 13.4.6.6.1.3. Channel Strategy
    • 13.4.7. Mallinckrodt
      • 13.4.7.1. Overview
      • 13.4.7.2. Product and Technology Portfolio
      • 13.4.7.3. Production Footprint
      • 13.4.7.4. Sales Footprint
      • 13.4.7.5. Channel Footprint
      • 13.4.7.6. Strategy
        • 13.4.7.6.1.1. Marketing Strategy
        • 13.4.7.6.1.2. Product Strategy
        • 13.4.7.6.1.3. Channel Strategy
    • 13.4.8. PERNIX Therapeutics
      • 13.4.8.1. Overview
      • 13.4.8.2. Product and Technology Portfolio
      • 13.4.8.3. Production Footprint
      • 13.4.8.4. Sales Footprint
      • 13.4.8.5. Channel Footprint
      • 13.4.8.6. Strategy
        • 13.4.8.6.1.1. Marketing Strategy
        • 13.4.8.6.1.2. Product Strategy
        • 13.4.8.6.1.3. Channel Strategy
    • 13.4.9. Takeda Pharmaceutical Company Limited
      • 13.4.9.1. Overview
      • 13.4.9.2. Product and Technology Portfolio
      • 13.4.9.3. Production Footprint
      • 13.4.9.4. Sales Footprint
      • 13.4.9.5. Channel Footprint
      • 13.4.9.6. Strategy
        • 13.4.9.6.1.1. Marketing Strategy
        • 13.4.9.6.1.2. Product Strategy
        • 13.4.9.6.1.3. Channel Strategy
    • 13.4.10. Sunovion Pharmaceuticals, Inc.
      • 13.4.10.1. Overview
      • 13.4.10.2. Product and Technology Portfolio
      • 13.4.10.3. Production Footprint
      • 13.4.10.4. Sales Footprint
      • 13.4.10.5. Channel Footprint
      • 13.4.10.6. Strategy
        • 13.4.10.6.1.1. Marketing Strategy
        • 13.4.10.6.1.2. Product Strategy
        • 13.4.10.6.1.3. Channel Strategy

14. Global Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026, By Region

  • 14.1.Introduction/Key Findings
  • 14.2.Historical Market Size (US$ Mn)Trend Analysis By Region, 2013-2017
  • 14.3.Market Size (US$ Mn) Forecast By Region, 2018-2026
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. Asia Pacific Excluding China
    • 14.3.5. China
    • 14.3.6. Middle East & Africa
  • 14.4.Market Attractiveness Analysis By Region

15. Global Insomnia Treatment Analysis 2013-2017 and Forecast 2018-2026, By Drug Type

  • 15.1.Introduction/Key Findings
  • 15.2.Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 15.2.1. OTC Drugs
      • 15.2.1.1. OTC Sleep Aids
      • 15.2.1.2. OTC Sleep Supplements
    • 15.2.2. Prescription Drugs
  • 15.3.Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 15.4.Market Attractiveness Analysis By Drug Type

16. Global Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

  • 16.1.Introduction/Key Findings
  • 16.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 16.2.1. Hospital Pharmacies
    • 16.2.2. Retail Pharmacies
    • 16.2.3. e commerce
    • 16.2.4. Drug Stores
    • 16.2.5. Others
  • 16.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 16.4.Market Attractiveness Analysis By Distribution Channel

17. Global Insomnia Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 17.1.Market Value Share Analysis
  • 17.2.Y-o-Y Growth Analysis
  • 17.3.Absolute $ Opportunity

18. Research Methodology

List of Tables

  • Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
  • Table 03: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 04: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 05: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 06: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 07: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 08: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 09: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 10: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 11: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 12: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 13: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 14: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 15: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 16: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 17: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 18: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
  • Table 19: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 20: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

List of Figures

  • Figure 01: Country wise Prevalence of Insomnia, 2016
  • Figure 02: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005-2010
  • Figure 03: Global Healthcare Expenditure in US$ Tn (2013-2020)
  • Figure 04: North America Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
  • Figure 05: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 06: North America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 07: North America Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 08: U.S. Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 09: U.S. Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 10: Canada Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 11: Canada Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 12: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By OTC Drugs
  • Figure 13: North America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By OTC Drugs
  • Figure 14: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By Prescription Drugs
  • Figure 15: North America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Prescription Drugs
  • Figure 16: North America Insomnia Treatment Market Attractiveness Analysis, By Country
  • Figure 17: North America Insomnia Treatment Market Attractiveness Analysis, By Drug Type
  • Figure 18: North America Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 19: Latin America Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
  • Figure 20: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 21: Latin America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 22: Latin America Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 23: Brazil Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 24: Brazil Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 25: Mexico Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 26: Mexico Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 27: Rest of Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 28: Rest of Latin America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 29: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By OTC Drugs
  • Figure 30: Latin America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By OTC Drugs
  • Figure 31: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By Prescription Drugs
  • Figure 32: Latin America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Prescription Drugs
  • Figure 33: Latin America Insomnia Treatment Market Attractiveness Analysis, By Country
  • Figure 34: Latin America Insomnia Treatment Market Attractiveness Analysis, By Drug Type
  • Figure 35: Latin America Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 36: Europe Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
  • Figure 37: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 38: Europe Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 39: Europe Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 40: Germany Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 41: Germany Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 42: U.K. Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 43: U.K. Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 44: France Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 45: France Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 46: Italy Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 47: Italy Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 48: Spain Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 49: Spain Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 50: Russia Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 51: Russia Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 52: Poland Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 53: Poland Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 54: Rest of Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 55: Rest of Europe Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 56: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By OTC Drugs
  • Figure 57: Europe Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By OTC Drugs
  • Figure 58: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By Prescription Drugs
  • Figure 59: Europe Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Prescription Drugs
  • Figure 60: Europe Insomnia Treatment Market Attractiveness Analysis, By Country
  • Figure 61: Europe Insomnia Treatment Market Attractiveness Analysis, By Drug Type
  • Figure 62: Europe Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 63: Asia Pacific Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
  • Figure 64: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 65: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 66: Asia Pacific Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 67: China Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 68: China Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 69: India Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 70: India Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 71: Japan Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 72: Japan Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 73: Australia & New Zealand Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 74: Australia & New Zealand Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 75: ASEAN Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 76: ASEAN Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 77: Rest of Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 78: Rest of Asia Pacific Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 79: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By OTC Drugs
  • Figure 80: Asia Pacific Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By OTC Drugs
  • Figure 81: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By Prescription Drugs
  • Figure 82: Asia Pacific Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Prescription Drugs
  • Figure 83: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Country
  • Figure 84: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Drug Type
  • Figure 85: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 86: Middle East and Africa Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
  • Figure 87: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 88: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 89: Middle East and Africa Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
  • Figure 90: GCC Countries Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 91: GCC Countries Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 92: South Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 93: South Africa Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 94: Rest of MEA Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 95: Rest of MEA Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
  • Figure 96: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By OTC Drugs
  • Figure 97: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By OTC Drugs
  • Figure 98: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017, By Prescription Drugs
  • Figure 99: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026, By Prescription Drugs
  • Figure 100: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Country
  • Figure 101: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Drug Type
  • Figure 102: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 103: Global Insomnia Treatment Market Attractiveness Analysis, By Region
  • Figure 104: Global Insomnia Treatment Market Attractiveness Analysis, By Drug Type
  • Figure 105: Global Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 106: Global Insomnia Treatment Market Size and Y-o-Y, 2013 - 2017
  • Figure 107: Global Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 108: Global Insomnia Treatment Market Absolute $ Opportunity, 2017-2026
Back to Top